Advanced Life Sciences to Be Featured at 2002 Illinois Venture Capital Conference

Woodridge, Ill, September 25, 2002 - Advanced Life Sciences, Inc. (ALS) will be one of the elite high-growth Mid-American companies showcased at the 2002 Illinois Venture Capital Conference to be held tomorrow at the Chicago Marriott. The conference sponsors selected 17 companies, including ALS, for presentation that already have seed capital, a developed product and quality management.

Michael T. Flavin, Ph.D., ALS's chief executive officer will outline ALS's technology, products and business plans to an audience of more than 500 investors and institutional venture capitalists.

Advanced Life Sciences is a privately held biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer, and inflammation using its platform in natural products and chemical proteomics coupled with expertise in drug development. (